JTO Clinical and Research Reports : Impact Factor & More
eISSN: 2666-3643
Open AccessShare this on:
Key Metrics
CiteScore 
1
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on JTO Clinical and Research Reports
JTO Clinical and Research Reports Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | Elsevier |
| Language | English |
| Article Processing Charges | USD 2000 |
| Publication Time | 19 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | International Association for the Study of Lung Cancer |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in JTO Clinical and Research Reports ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in JTO Clinical and Research Reports
A Rare Metastatic Fibrous Tumor: Review of Literature With a Case Report
- 1 Dec 2025
- JTO Clinical and Research Reports
Durvalumab in Patients With Treatment-Naive Stage IV NSCLC With an ECOG Performance Status of 2 to 3 and High PD-L1 Tumor Expression (IFCT-1802 SAVIMMUNE): A Multicenter Phase 2 Trial
- 1 Dec 2025
- JTO Clinical and Research Reports
Unmasking the Hidden Cardiopulmonary Cost of Lobectomy: A Paradigm Shift Demanded by Exercise Hemodynamics
- 1 Nov 2025
- JTO Clinical and Research Reports
Central Nervous System Progression in Patients Receiving ALK-Targeted Central Nervous System–Penetrable Tyrosine Kinase Inhibitors: Treatment Patterns and Outcomes
- 3 Oct 2025
- JTO Clinical and Research Reports
The added value of genome-wide copy numbers to objectively resolve clonality of multiple tumors with pulmonary involvement and ambiguous or inconclusive mutational diagnosis
- 1 Oct 2025
- JTO Clinical and Research Reports
Brief Report: MET driven resistance to sotorasib in KRAS G12C-mutant Non-small cell lung cancer and response to combined KRAS and MET inhibition
- 1 Oct 2025
- JTO Clinical and Research Reports
A Rare Metastatic Fibrous Tumor: Review of Literature With a Case Report
- 1 Dec 2025
- JTO Clinical and Research Reports
Durvalumab in Patients With Treatment-Naive Stage IV NSCLC With an ECOG Performance Status of 2 to 3 and High PD-L1 Tumor Expression (IFCT-1802 SAVIMMUNE): A Multicenter Phase 2 Trial
- 1 Dec 2025
- JTO Clinical and Research Reports
Unmasking the Hidden Cardiopulmonary Cost of Lobectomy: A Paradigm Shift Demanded by Exercise Hemodynamics
- 1 Nov 2025
- JTO Clinical and Research Reports
Central Nervous System Progression in Patients Receiving ALK-Targeted Central Nervous System–Penetrable Tyrosine Kinase Inhibitors: Treatment Patterns and Outcomes
- 3 Oct 2025
- JTO Clinical and Research Reports
The added value of genome-wide copy numbers to objectively resolve clonality of multiple tumors with pulmonary involvement and ambiguous or inconclusive mutational diagnosis
- 1 Oct 2025
- JTO Clinical and Research Reports
Brief Report: MET driven resistance to sotorasib in KRAS G12C-mutant Non-small cell lung cancer and response to combined KRAS and MET inhibition
- 1 Oct 2025
- JTO Clinical and Research Reports
FAQs on JTO Clinical and Research Reports
How many articles did JTO Clinical and Research Reports publish last year? 
What is Citescore for JTO Clinical and Research Reports?
Who is the publisher of JTO Clinical and Research Reports?
